References
- Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China [published correction appears in Nature]. Nature. 2020;579(7798):265–269.
- Kinoshita M, Tanaka M. Impact of Routine Infant BCG Vaccination on COVID-19. J Infect. 2020;81(4):625–633.
- Mutambudzi M, Niedwiedz C, Macdonald EB, et al. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup Environ Med. 2020. DOI:https://doi.org/10.1136/oemed-2020-106731.
- Sharma A, Kumar Sharma S, Shi Y, et al. BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic? Cell Death Dis. 2020;11(7):516.
- Zwerling A, Behr MA, Verma A, et al. The BCG World Atlas: a Database of Global BCG Vaccination Policies and Practices. PLoS Medicine. 2011;8(3):e1001012.
- Lerm M. On the relationship between BCG coverage and national COVID-19 outcome: could ‘heterologous’ herd immunity explain why some countries are better off? J Intern Med. 2020;288(6):682–688.
- Miller A, Reandelar MJ, Fasciglione K, et al. (2020). Correlation between universal BCG vaccination policy and reduced mortality for COVID-19.
- Saatçi E. COVID-19 Pandemisi ve Sağlık Çalışanları. Türkiye Aile Hekimliği Dergisi. 2020;24(4):172–174.
- COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. 2021. National Institutes of Health. Accessed 2021 Mar 28. https://www.covid19treatmentguidelines.nih.gov/
- Rolewicz L, Palmer B (2020). The NHS workforce in numbers. Retrieved from https://www.nuffieldtrust.org.uk/resource/the-nhs-workforce-in-numbers
- Burrer SL, De Perio MA, Hughes MM, CDC COVID-19 Response Team. Characteristics of Health Care Personnel with COVID-19 — united States, February 12–April 9, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):477–481. .
- Lazzerini M, Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. The Lancet Global Health. 2020;8(5):e641–e642.
- Rivett L, Sridhar S, Sparkes D, et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. Elife. 2020;9:e58728.
- Kluytmans-van Den Bergh MFQ, Buiting AGM, Pas SD, et al. Prevalence and Clinical Presentation of Health Care Workers With Symptoms of Coronavirus Disease 2019 in 2 Dutch Hospitals During an Early Phase of the Pandemic. JAMA Network Open. 2020;3(5):e209673.
- Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
- CDC Weekly C. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — china, 2020. China CDC Weekly. 2020;2(8):113–122.
- Yitbarek K, Abraham G, Girma T, et al. The effect of Bacillus Calmette–Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: implications for the COVID-19 pandemic. Vaccine. 2020;38(41):6374–6380.
- Ozkaya S, Uzar T, Karaman I, et al. Could BCG vaccine provide immunization against COVID-19? A potential relationship between Mycobacterium immunization and SARS-CoV-2. Minerva Pneumologica. 2020;59(3):3.
- Koeken VACM, Verrall AJ, Netea MG, et al. Trained innate immunity and resistance to Mycobacterium tuberculosis infection. Clin Microbiol Infect. 2019;25(12):1468–1472.
- Joosten SA, Van Meijgaarden KE, Arend SM, et al. Mycobacterial growth inhibition is associated with trained innate immunity. J Clin Invest. 2018;128(5):1837–1851.
- Khan N, Downey J, Sanz J, et al. M. tuberculosis Reprograms Hematopoietic Stem Cells to Limit Myelopoiesis and Impair Trained Immunity. Cell. 2020;183(3):752–770.
- Urbán S, Paragi G, Burián K, et al. Identification of similar epitopes between severe acute respiratory syndrome coronavirus-2 and Bacillus Calmette–Guérin: potential for cross-reactive adaptive immunity. Clin Transl Immunology. 2020;9(12):e1227.
- Singh S, Maurya RP, Singh RK. “Trained immunity” from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes. PLoS Pathog. 2020;16(10):e1008969.
- Covián C, Retamal-Díaz A, Bueno SM, et al. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2? Front Immunol. 2020;11:970.
- Netea MG, Giamarellos-Bourboulis EJ, Domínguez-Andrés J, et al. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection. Cell. 2020;181(5):969–977.
- Liu Y, Bi L, Chen Y, et al. (2020). Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedRxiv. https://doi.org/10.1101/2020.03.10.20033795
- Gao Y, Liu M, Chen Y, et al. Association between tuberculosis and COVID-19 severity and mortality: a rapid systematic review and meta-analysis [published online ahead of print, 2020 Jul 20]. J Med Virol. 2020. DOI:https://doi.org/10.1002/jmv.26311
- Noval Rivas M, Ebinger JE, Wu M, et al. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers. J Clin Invest. 2020;145157. DOI:https://doi.org/10.1172/JCI145157
- Weng C-H, Saal A, Butt WW, et al. Bacillus Calmette–Guérin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study. Epidemiol Infect. 2020;148:e140.
- Levi M, Miglietta A, Romeo G, et al. Letter in response to article in journal of infection: impact of routine infant BCG vaccination on COVID-19. The Journal of Infection. 2021;82(1):e41–e43.